ERK and p38 upregulation versus Bcl-6 downregulation in rat kidney epithelial cells exposed to prolonged hypoxia

Abstract

Hypoxia is a common cause of kidney injury and a major issue in kidney transplantation. Mitogen-activated protein kinases (MAPKs) are involved in the cellular response to hypoxia, but the precise roles of MAPKs in renal cell reactions to hypoxic stress are not well known yet. This work was conducted to investigate the regulation of extracellular signal-regulated kinase-1 and -2 (ERK1/2) and p38 and their signaling-relevant molecules in kidney epithelial cells exposed to prolonged hypoxia. Rat kidney epithelial cells Normal Rat Kidney (NRK)-52E were exposed to hypoxic conditions (1% O 2 ) for 24 to 72 h. Cell morphology was examined by light microscopy, and cell viability was checked by 3-The expression of ERK1/2 and p38 MAPK, as well as their signaling-related molecules, was measured by Western blot and real-time polymerase chain (RT-PCR) reaction. At the 1% oxygen level, cell morphology had no appreciable changes compared to the control up to 72 h of exposure under light microscopy, whereas the results of MTS showed a slight but significant reduction in cell viability after 72 h of hypoxia. On the other hand, ERK1/2 and p38 phosphorylation remarkably increased in these cells after 24 to 72 h of hypoxia. In sharp contrast, the expression of transcription factor B-cell lymphoma 6 (Bcl-6) was significantly downregulated in response to hypoxic stress. Other intracellular molecules relevant to the ERK1/2 and p38 signaling pathway, such as protein kinase A, protein kinase C, Bcl-2, nuclear factor erythroid 2-related factor 2, tristetraprolin, and interleukin-10(IL-10), had no significant alterations after 24 to 72 h of hypoxic exposure. We conclude that hypoxic stress increases the phosphorylation of both ERK1/2 and p38 but decreases the level of Bcl-6 in rat kidney epithelial cells.

Internal enhancement of DNA damage by a novel bispecific antibody‐drug conjugate‐like therapeutics via blockage of mTOR and PD‐L1 signal pathways in pancreatic cancer

“…There were inevitably some limitations in our study: (a) The fluorescent signals of DTLL distribution from our in vivo targeting imaging test were not very strong or highly specific, being weaker than that of the full‐size antibody probably due to its smaller size and shorter half‐life ( t 1/2 ). (b) DTLL was designed to target EGFR and HER2 within the same ErbB signaling pathway by a similar mechanism of action . This might make it possible to partially acquire resistance because there would be adaptive responses involved in other potential alternative pathways.…”

Pathogenic effect of a cell-penetrating anti-dsDNA autoantibody through p38 signaling pathway and pro-inflammatory cytokine stimulation in mesangial cells

“…Similarly, there have been reports showing that RSK-1 was activated by p38 rather than by ERK1/2 in kidney epithelial or dendritic cells (Zaru et al 2007(Zaru et al , 2015Luo et al 2017). In 2C10 IgG and VH treated MES cells, p38-dependent MAPKAPK-2 activation and MAPKAPK-2-dependent RSK-1 activation were induced.…”

Effects of long-term tubular HIF-2α overexpression on progressive renal fibrosis in a chronic kidney disease model

“…EMT occurred at 24 hr and then decreased over time at 48 and 72 hr. The relationship between renal fibrosis and the MAPK pathway is well known; however, the precise roles of MAPKs in the renal cell response to hypoxia are unknown (22). Next, we evaluated the p-p38 levels in TECs treated with DOX and TGF-β1.…”